Pfizer jettisons IVD line
This article was originally published in The Gray Sheet
Executive Summary
European private equity firm Triton and PPM Ventures, an arm of Prudential, acquire in vitro allergy and autoimmune diagnostic testing business from Pfizer for $575 mil. Divestiture of the Sweden-based business had been projected since July, one year after the drug giant bought Pharmacia (1"The Gray Sheet" July 7, 2003, p. 8)...